Working… Menu

A Phase I Trial to Evaluate the Safety and Immunogenicity of eOD-GT8 60mer Vaccine, Adjuvanted

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03547245
Recruitment Status : Active, not recruiting
First Posted : June 6, 2018
Last Update Posted : February 5, 2020
Information provided by (Responsible Party):
International AIDS Vaccine Initiative

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : January 17, 2020
Estimated Study Completion Date : December 31, 2020